Skip to main content

Table 1 Baseline characteristics

From: High admission glucose levels increase Fas apoptosis and mortality in patients with acute ST-elevation myocardial infarction: a prospective cohort study

  Normal glucose group Median glucose group High glucose group
(n = 33) (n = 24) (n = 26)
Age (y) 58 ± 11 61 ± 10 59 ± 11
Male (%) 28 (84.8%) 20 (83.3%) 18 (69.2%)
BMI (kg/m2) 25.3 ± 1.8 25.0 ± 2.7 25.7 ± 2.5
Medical history
Hypertension, n (%) 20 (60.6%) 19 (79.2%) 21 (80.8%)
Previous diabetes, n (%) 2 (6.1%) 6 (25.0%) 12 (46.2%)*
Previous angina, n (%) 5 (15.1%) 3 (12.5%) 3 (11.5%)
Atrial fibrillation, n (%) 0 (0%) 0 (0%) 1 (3.8%)
Current smoker, n (%) 21 (63.3%) 15 (62.5%) 20 (76.9%)
Biochemical data
Cholesterol (mmol/L) 4.81 ± 0.85 4.46 ± 1.13 4.80 ± 1.21
LDL-cholesterol (mmol/L) 2.78 ± 0.68 2.57 ± 0.75 2.78 ± 0.83
HDL-cholesterol (mmol/L) 1.02 ± 0.22 0.95 ± 0.26 0.96 ± 0.21
Triglycerides (mmol/L) 1.31 ± 0.65 1.27 ± 0.83 1.98 ± 1.42*
hsCRP (mg/L) 3.2 ± 2.8 2.3 ± 1.6 3.7 ± 4.5
CKMB (IU/L) 137.9 ± 96.9 145.7 ± 85.5 100.6 ± 89.5
Creatinine (μmol/L) 91.48 ± 29.34 85.04 ± 26.74 96.15 ± 19.31
GFR (ml/min) 78.22 ± 24.28 79.43 ± 27.45 70.90 ± 15.85
HbA1C (%) 4.5 ± 1.1 5.3 ± 1.2 7.6 ± 2.0*, #
Admission plasma glucose level (mmol/L) 6.3 ± 0.9 9.1 ± 0.9 14.5 ± 3.4*, #
Clinical aspects of STEMI
Ischemia time
Symptom-to-enrollement, min 355 ± 162 340 ± 151 346 ± 180
Symptom-to-ballon, min 419 ± 159 409 ± 149 414 ± 183
Infarct site: Anterior 51.5% 54.2% 57.7%
Infarct related artery
  LAD, n (%) 18 (55%) 11 (46%) 13 (50%)
  LCX, n (%) 3 (9%) 3 (13%) 3 (11%)
  RCA, n (%) 12 (36%) 10 (42%) 10 (38%)
Number of diseased vessels
 1 coronary vessel (%) 23 (70%) 17 (71%) 16 (62%)
 2 coronary vessels (%) 8 (24%) 6 (25%) 8 (31%)
 3 coronary vessels (%) 2 (6%) 1 (4%) 2 (7%)
Number of stent implanted 1.48 ± 0.51 1.58 ± 0.50 1.50 ± 0.51
Stent type
 Bare-metal stent, (%) 44% 39% 38%
 Drug-eluting stent, (%) 56% 61% 62%
  1. BMI body mass index; HDL high-density lipoprotein; hsCRP high-sensitivity C-reactive protein; LDL low-density lipoprotein; CKMB creatine kinase isoenzyme MB; GFR glomerular filtration rate; HbA1C glycosylated hemoglobin;
  2. * P < 0.05 for the high glucose group versus the normal glucose group.
  3. #P < 0.05 for the high glucose group versus the median glucose group.
  4. P < 0.05 for the median glucose group versus the normal glucose group.